156 related articles for article (PubMed ID: 29850387)
1. Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator.
Khalid M; Kanaa M; Alkawaleet Y; Ayub MT
Cureus; 2018 Mar; 10(3):e2392. PubMed ID: 29850387
[TBL] [Abstract][Full Text] [Related]
2. Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.
Duymun S; Reddy V; Bentley E; Bose-Kolanu A
Am J Case Rep; 2021 Jan; 22():e927137. PubMed ID: 33441533
[TBL] [Abstract][Full Text] [Related]
3. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
Burd M; McPheeters C; Scherrer LA
Adv Emerg Nurs J; 2019; 41(3):204-214. PubMed ID: 31356244
[TBL] [Abstract][Full Text] [Related]
4. A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
Pahs L; Droege C; Kneale H; Pancioli A
Ann Emerg Med; 2016 Sep; 68(3):345-8. PubMed ID: 27174372
[TBL] [Abstract][Full Text] [Related]
5. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.
Engelter ST; Fluri F; Buitrago-Téllez C; Marsch S; Steck AJ; Rüegg S; Lyrer PA
J Neurol; 2005 Oct; 252(10):1167-70. PubMed ID: 16184341
[TBL] [Abstract][Full Text] [Related]
6. Angioedema after tPA: what neurointensivists should know.
Fugate JE; Kalimullah EA; Wijdicks EF
Neurocrit Care; 2012 Jun; 16(3):440-3. PubMed ID: 22311232
[TBL] [Abstract][Full Text] [Related]
7. Orolingual angioedema after alteplase therapy of acute ischaemic stroke: incidence and risk of prior angiotensin-converting enzyme inhibitor use.
Lin SY; Tang SC; Tsai LK; Yeh SJ; Hsiao YJ; Chen YW; Chen KH; Yip BS; Shen LJ; Wu FL; Jeng JS
Eur J Neurol; 2014 Oct; 21(10):1285-91. PubMed ID: 24909847
[TBL] [Abstract][Full Text] [Related]
8. Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.
Marceau F; Rivard GE; Gauthier JM; Binkley KE; Bonnefoy A; Boccon-Gibod I; Bouillet L; Picard M; Levesque G; Elfassy HL; Bachelard H; Hébert J; Bork K
Front Med (Lausanne); 2020; 7():358. PubMed ID: 32766265
[TBL] [Abstract][Full Text] [Related]
9. Angioedema from recombinant TPA administration: case report and pathophysiology review.
Foster-Goldman A; McCarthy D
Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme Inhibitors and Other Medications Associated With Angioedema.
Landry L; Witten T; Anwar AI; Jackson CN; Talbot NC; Ahmadzadeh S; Varrassi G; Shekoohi S; Kaye AD
Cureus; 2023 Nov; 15(11):e49306. PubMed ID: 38957198
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity reactions to recombinant tissue plasminogen activator.
Alakbarzade V; O'Kane D; Pereira AC
Pract Neurol; 2020 Feb; 20(1):75-79. PubMed ID: 31273082
[TBL] [Abstract][Full Text] [Related]
12. Audit report and systematic review of orolingual angioedema in post-acute stroke thrombolysis.
Lekoubou A; Philippeau F; Derex L; Olaru A; Gouttard M; Vieillart A; Kengne AP
Neurol Res; 2014 Jul; 36(7):687-94. PubMed ID: 24620962
[TBL] [Abstract][Full Text] [Related]
13. A Case Report of Unilateral Orolingual Angioedema Secondary to Alteplase Administration.
Harris D; Harter D
Cureus; 2018 Jun; 10(6):e2869. PubMed ID: 30148021
[TBL] [Abstract][Full Text] [Related]
14. Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report.
Kim C; Hladik A
Clin Pract Cases Emerg Med; 2021 May; 5(2):159-162. PubMed ID: 34436994
[TBL] [Abstract][Full Text] [Related]
15. Incidence, predictors and clinical characteristics of orolingual angio-oedema complicating thrombolysis with tissue plasminogen activator for ischaemic stroke.
Hurford R; Rezvani S; Kreimei M; Herbert A; Vail A; Parry-Jones AR; Douglass C; Molloy J; Alachkar H; Tyrrell PJ; Smith CJ
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):520-3. PubMed ID: 25016564
[TBL] [Abstract][Full Text] [Related]
16. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke.
Hill MD; Lye T; Moss H; Barber PA; Demchuk AM; Newcommon NJ; Green TL; Kenney C; Cole-Haskayne A; Buchan AM
Neurology; 2003 May; 60(9):1525-7. PubMed ID: 12743244
[TBL] [Abstract][Full Text] [Related]
17. Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency.
Rathbun KM
Oxf Med Case Reports; 2019 Jan; 2019(1):omy112. PubMed ID: 30697429
[TBL] [Abstract][Full Text] [Related]
18. Orolingual angiodema associated with alteplase treatment of acute stroke: a reappraisal.
Correia AS; Matias G; Calado S; Lourenço A; Viana-Baptista M
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):31-40. PubMed ID: 25440357
[TBL] [Abstract][Full Text] [Related]
19. Anaphylactoid reaction to recombinant tissue plasminogen activator.
Krmpotic KR; Fernandes CM
Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
[TBL] [Abstract][Full Text] [Related]
20. Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents.
Sczepanski M; Bozyk P
Crit Care Res Pract; 2018; 2018():9360918. PubMed ID: 30363665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
